Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Pertussis.

Artykuły w czasopismach na temat „Pertussis”

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Pertussis”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.

1

Schneider, Ferenc, Éva Stánitz, Judit Kalácska, Tünde Tompity, and Beáta Gábor. "Whooping cough in an urban high school in Hungary. Conclusions of a local pertussis outbreak." Orvosi Hetilap 150, no. 33 (2009): 1557–61. http://dx.doi.org/10.1556/oh.2009.28655.

Pełny tekst źródła
Streszczenie:
A pertussis a védőoltás bevezetésével fokozatosan visszaszoruló fertőző betegség lett, de teljes eradikációja nem lehetséges. Ezt mutatják a nemzetközi és a hazai adatok is. Az ezredforduló után a pertussisos megbetegedések lassú növekedése figyelhető meg. Célkitűzés: Az adolescens pertussis klinikumának bemutatása egy helyi járvány kapcsán, ezzel egyidejűleg a pertussis jelenlétének demonstrálása a hazai populációban. Módszer: Az első felismert 18 éves beteg környezetében retrospektív adatgyűjtéssel felderített, tartósan köhögő betegektől vett vérmintából emelkedő pertussis-antitoxin-IgG megh
Style APA, Harvard, Vancouver, ISO itp.
2

Juliska, Shelly, Rico J. Sitorus, and Hamzah Hasyim. "FAKTOR RISIKO KEJADIAN PERTUSIS PADA BAYI DAN ANAK – ANAK (SISTEMATIK LITERATURE REVIEW)." Mitra Raflesia (Journal of Health Science) 16, no. 2 (2024): 50–58. https://doi.org/10.51712/mitraraflesia.v16i2.394.

Pełny tekst źródła
Streszczenie:
ABSTRAKPendahuluan: Kebangkitan (resurgence) pertusis saat ini terjadi hampir di seluruh dunia dengan insiden tertinggi terjadi pada bayi dan menyebabkan kematian pada kasus pertusis berat. Kasus kematian yang terjadi umumnya ditemukan pada bayi berusia < 6 bulan akibat komplikasi pertusis. Tujuan dari penyusunan studi literature ini adalah untuk mempelajari tentang faktor risiko infeksi pertusis pada bayi dan anak-anak. Metode : Metode yang digunakan yaitu studi literatur (literature review) Â yang disusun melalui penelusuran literatur terkait pertusis menggunakan metode PRISMA (Preferred
Style APA, Harvard, Vancouver, ISO itp.
3

Tjahjowargo, Sendy, and Hartono Gunardi. "Perbandingan Efektivitas dan Keamanan Vaksin Pertusis Aselular dan Whole-cell." Sari Pediatri 18, no. 5 (2017): 403. http://dx.doi.org/10.14238/sp18.5.2017.403-8.

Pełny tekst źródła
Streszczenie:
Latar belakang. Imunisasi merupakan upaya pencegahan terbaik terhadap berbagai penyakit infeksi. Vaksin difteri, tetanus, pertusis whole-cell (DTwP) dapat menimbulkan kejadian ikutan pasca imunisasi (KIPI) yang mengkhawatirkan orangtua. Vaksin difteri, tetanus, pertusis aselular (DTaP) memiliki KIPI lebih ringan, tetapi diduga kurang efektif. Tujuan. Mengetahui efektivitas vaksin DTaP dibandingkan dengan vaksin DTwP.Metode. Penelusuran literatur elektronik PubMed dan Cochrane dengan kata kunci “DTaP/acellular pertussis”, “DTwP/whole-cell pertussis”, “children”, “pertussis”, “vaccine” and “safe
Style APA, Harvard, Vancouver, ISO itp.
4

Zadorozhnaya, V. I., A. P. Podavalenko, and N. I. Operchuk. "Risk of an Intensification of Pertussis Epidemic and its Vaccinal Prevention Process in Ukraine." Epidemiology and Vaccine Prevention 14, no. 1 (2015): 78–82. http://dx.doi.org/10.31631/2073-3046-2015-14-1-78-82.

Pełny tekst źródła
Streszczenie:
The pertussis epidemic process is characterized by cyclical ups 2-5 years, high level of child and town population morbidity. Longterm pertussis morbidity dynamics in Ukraine tends to increase. Low coverage of a pertusiss immunization of the children's population, increase of immunocompromised individuals in the population, deterioration of social, economic and ecological factors are adverse conditions for a current of the pertussis epidemic process. The first priority is to maintain an appropriate level of routine immunization of children with increased attention to immunocompromised persons.
Style APA, Harvard, Vancouver, ISO itp.
5

Kilgore, Paul E., Abdulbaset M. Salim, Marcus J. Zervos, and Heinz-Josef Schmitt. "Pertussis: Microbiology, Disease, Treatment, and Prevention." Clinical Microbiology Reviews 29, no. 3 (2016): 449–86. http://dx.doi.org/10.1128/cmr.00083-15.

Pełny tekst źródła
Streszczenie:
SUMMARYPertussis is a severe respiratory infection caused byBordetella pertussis, and in 2008, pertussis was associated with an estimated 16 million cases and 195,000 deaths globally. Sizeable outbreaks of pertussis have been reported over the past 5 years, and disease reemergence has been the focus of international attention to develop a deeper understanding of pathogen virulence and genetic evolution ofB. pertussisstrains. During the past 20 years, the scientific community has recognized pertussis among adults as well as infants and children. Increased recognition that older children and ado
Style APA, Harvard, Vancouver, ISO itp.
6

Conly, John M., and B. Lynn Johnston. "The Role of the Aceullular Pertussis Vaccine and the Comeback of 'Pertussis Pete'?" Canadian Journal of Infectious Diseases 12, no. 1 (2001): 15–17. http://dx.doi.org/10.1155/2001/839183.

Pełny tekst źródła
Streszczenie:
Pertussis or whooping cough is an acute infectious disease of the respiratory tract caused principally byBordetella pertussisand less commonly byBordetella parapertussis(1). Until two decades ago, pertussis in adults was a medical curiosity (2-4), but with the purification of specificBordetellaspecies antigens, the development of reliable enzyme immunoassays allowing accurate serological diagnosis and better understanding of the duration of immunity from vaccination, it has been clearly demonstrated thatB pertussisis a common cause of prolonged cough in adults. Indeed, its incidence has been i
Style APA, Harvard, Vancouver, ISO itp.
7

Pascual, F. Brian, Candace L. McCall, Aaron McMurtray, Tony Payton, Forrest Smith, and Kristine M. Bisgard. "Outbreak of Pertussis Among Healthcare Workers in a Hospital Surgical Unit." Infection Control & Hospital Epidemiology 27, no. 6 (2006): 546–52. http://dx.doi.org/10.1086/506232.

Pełny tekst źródła
Streszczenie:
Background.In September 1999, a pertussis outbreak was detected among surgical staff of a 138-bed community hospital. Patients were exposed toBordetella pertussisduring the 3-month outbreak period.Objective.To describe the outbreak among surgical staff, to evaluate implemented control measures, and to determine whether nosocomial transmission occurred.Methods.Clinical pertussis was defined as acute cough illness with a duration of 14 days or more without another apparent cause; persons with positive culture, PCR, or serologic test results were defined as having laboratory-confirmed pertussis.
Style APA, Harvard, Vancouver, ISO itp.
8

Daniels, Heather L., and Camille Sabella. "Bordetella pertussis (Pertussis)." Pediatrics in Review 39, no. 5 (2018): 247–57. http://dx.doi.org/10.1542/pir.2017-0229.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Kandola, Kami, Amy Lea, Wanda White, and Maria Santos. "A Comparison of Pertussis Rates in the Northwest Territories: Pre- and Postacellular Pertussis Vaccine Introduction in Children and Adolescents." Canadian Journal of Infectious Diseases and Medical Microbiology 16, no. 5 (2005): 271–74. http://dx.doi.org/10.1155/2005/642315.

Pełny tekst źródła
Streszczenie:
INTRODUCTION: During the past decade, a trend toward increasing cases ofBordetella pertussisin older children and adults has been witnessed in Canada. The National Advisory Committee on Immunization now recommends that the adult formulation of the acellular pertussis (adult dTap) vaccine combined with diphtheria and tetanus toxoids be substituted for diphtheria and tetanus toxoids alone for the 14- to 16-year-old booster dose. In October 2000, the government of the Northwest Territories was one of the first to adopt adult dTap into their territorial immunization program free of charge.OBJECTIV
Style APA, Harvard, Vancouver, ISO itp.
10

Zhang, Xuqing, Sara E. Hester, Mary J. Kennett, et al. "Interleukin-1 Receptor Signaling Is Required To Overcome the Effects of Pertussis Toxin and for Efficient Infection- or Vaccination-Induced Immunity againstBordetella pertussis." Infection and Immunity 79, no. 1 (2010): 527–41. http://dx.doi.org/10.1128/iai.00590-10.

Pełny tekst źródła
Streszczenie:
ABSTRACTInterleukin-1 receptor-deficient (IL-1R−/−) mice are healthy despite being colonized by commensal microbes but are defective in defenses against specific pathogens, suggesting that IL-1R-mediated effects contribute to immune responses against specific pathogenic mechanisms. To better define the role of IL-1R in immunity to respiratory infections, we challenged IL-1R−/−mice withBordetella pertussisandBordetella parapertussis, the causative agents of whooping cough. Following inoculation withB. pertussis, but notB. parapertussis, IL-1R−/−mice showed elevated bacterial numbers and more ex
Style APA, Harvard, Vancouver, ISO itp.
11

Aase, Audun, Tove Karin Herstad, Samuel Merino, et al. "Immunization of Teenagers with a Fifth Dose of Reduced DTaP-IPV Induces High Levels of Pertussis Antibodies with a Significant Increase in Opsonophagocytic Activity." Clinical and Vaccine Immunology 18, no. 8 (2011): 1269–74. http://dx.doi.org/10.1128/cvi.05067-11.

Pełny tekst źródła
Streszczenie:
ABSTRACTWaning vaccine-induced immunity againstBordetella pertussisis observed among adolescents and adults. A high incidence of pertussis has been reported in this population, which serves as a reservoir forB. pertussis. A fifth dose of reduced antigen of diphtheria-tetanus-acellular-pertussis and inactivated polio vaccine was given as a booster dose to healthy teenagers. The antibody activity againstB. pertussisantigens was measured prior to and 4 to 8 weeks after the booster by different assays: enzyme-linked immunosorbent assays (ELISAs) of IgG and IgA against pertussis toxin (PT) and fila
Style APA, Harvard, Vancouver, ISO itp.
12

Pichichero, Michael E. "Pertussis and the pertussis vaccines." Current Opinion in Infectious Diseases 6, no. 4 (1993): 558–64. http://dx.doi.org/10.1097/00001432-199308000-00013.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
13

Handayani, Sarwo. "Profil Kekebalan Terhadap Difteri, Pertusis dan Tetanus pada Anak Umur di Bawah Lima Tahun, Hasil Riskesdas 2013." Buletin Penelitian Kesehatan 47, no. 3 (2019): 183–90. http://dx.doi.org/10.22435/bpk.v47i3.1503.

Pełny tekst źródła
Streszczenie:
Children under five years are a vulnerable group for diseases infection, therefore immunity to vaccine preventable diseases are essential, such as diphtheria, pertussis and tetanus. Those mentioned diseases, immunization is the most effective effort to reduce the mortality and morbidity. As a part of Basic Health Research analysis for samples collected in 2013, sera of 368 children under five years (aged 12-59 months) were tested for IgG to diphtheria, pertussis toxin and tetanus by ELISA method. The proportion of protective antibody associated with DPT immunization status obtained by univaria
Style APA, Harvard, Vancouver, ISO itp.
14

Fadugba, Olajumoke O., Li Wang, Qingxia Chen, and Natasha B. Halasa. "Immune Responses to Pertussis Antigens in Infants and Toddlers after Immunization with Multicomponent Acellular Pertussis Vaccine." Clinical and Vaccine Immunology 21, no. 12 (2014): 1613–19. http://dx.doi.org/10.1128/cvi.00438-14.

Pełny tekst źródła
Streszczenie:
ABSTRACTGiven the resurgence of pertussis despite high rates of vaccination with the diphtheria-tetanus-acellular pertussis (DTaP) vaccine, a better understanding of vaccine-induced immune responses toBordetella pertussisis needed. We investigated the antibody, cell-mediated, and cytokine responses toB. pertussisantigens in children who received the primary vaccination series (at 2, 4, and 6 months) and first booster vaccination (at 15 to 18 months) with 5-component acellular pertussis (aP) vaccine. The majority of subjects demonstrated a 4-fold increase in antibody titer to all four pertussis
Style APA, Harvard, Vancouver, ISO itp.
15

Burnett, Mark W. "Pertussis." Journal of Special Operations Medicine 13, no. 4 (2013): 113. http://dx.doi.org/10.55460/nb14-jh4h.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
16

Ang, Brenda. "Pertussis." Singapore Family Physician 45, no. 4 (2019): 15–17. http://dx.doi.org/10.33591/sfp.45.4.u3.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
17

Tompkins, Olga S. "Pertussis." AAOHN Journal 59, no. 6 (2011): 276. http://dx.doi.org/10.3928/08910162-20110525-04.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
18

Galiza, Eva P., Anna Calvert, Simon B. Drysdale, and Paul T. Heath. "Pertussis." Medicine 49, no. 12 (2021): 739–42. http://dx.doi.org/10.1016/j.mpmed.2021.09.002.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
19

Saks, Mark. "Pertussis." Emergency Medicine News 28, no. 6 (2006): 13–14. http://dx.doi.org/10.1097/00132981-200606000-00014.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
20

Liese, J. "Pertussis." Kinder- und Jugendmedizin 11, no. 03 (2011): 144–46. http://dx.doi.org/10.1055/s-0038-1629134.

Pełny tekst źródła
Streszczenie:
ZusammenfassungPertussis, die häufigste Form des Keuchhus-tens, ist eine Infektionskrankheit des Respirationstraktes, die durch Bordetella pertussis verursacht wird. In ungeimpften Populationen tritt Pertussis überwiegend im Alter zwischen zwei und sechs Jahren auf. In Populationen mit einer hohen Pertussis-Durchimpfungsrate im Kindesalter wird eine Verschiebung von Pertussiserkrankungen in das Adoleszentenund Erwachsenenalter beobachtet. Dadurch entstehen neue Übertragungswege auf junge, oft ungeimpfte Säuglinge. Diese wiederum haben das höchste Risiko für einen schweren Verlauf der Pertussis
Style APA, Harvard, Vancouver, ISO itp.
21

Chiocca, Ellen M. "Pertussis." Nursing 36, no. 7 (2006): 72. http://dx.doi.org/10.1097/00152193-200607000-00051.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
22

Heath, Paul T., and Louise A. Denvir. "Pertussis." Medicine 29, no. 3 (2001): 91–93. http://dx.doi.org/10.1383/medc.29.3.91.27599.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
23

Sinha, Ruchi, and Paul T. Heath. "Pertussis." Medicine 33, no. 5 (2005): 101–2. http://dx.doi.org/10.1383/medc.33.5.101.64962.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
24

Andersen, Erin. "Pertussis." AAOHN Journal 52, no. 12 (2004): 498–99. http://dx.doi.org/10.1177/216507990405201202.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
25

Olga, S. Tompkins. "Pertussis." AAOHN Journal 59, no. 6 (2011): 276. http://dx.doi.org/10.1177/216507991105900606.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
26

Heininger, Ulrich. "Pertussis." Pediatric Infectious Disease Journal 31, no. 1 (2012): 78–79. http://dx.doi.org/10.1097/inf.0b013e31823b034e.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
27

Galiza, Eva P., and Paul T. Heath. "Pertussis." Medicine 37, no. 12 (2009): 635–37. http://dx.doi.org/10.1016/j.mpmed.2009.09.007.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
28

Kent, Alison, and Paul T. Heath. "Pertussis." Medicine 42, no. 1 (2014): 8–10. http://dx.doi.org/10.1016/j.mpmed.2013.10.007.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
29

Calvert, Anna, and Paul T. Heath. "Pertussis." Medicine 45, no. 12 (2017): 735–38. http://dx.doi.org/10.1016/j.mpmed.2017.09.015.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
30

Nguyen, Van Tuong Ngoc, and Lauren Simon. "Pertussis." Primary Care: Clinics in Office Practice 45, no. 3 (2018): 423–31. http://dx.doi.org/10.1016/j.pop.2018.05.003.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
31

Schweon, Steven J. "Pertussis." Nursing 41, no. 10 (2011): 61–62. http://dx.doi.org/10.1097/01.nurse.0000405118.16392.86.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
32

Spector, Tara B., and Eileen K. Maziarz. "Pertussis." Medical Clinics of North America 97, no. 4 (2013): 537–52. http://dx.doi.org/10.1016/j.mcna.2013.02.004.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
33

Leber, Amy L. "Pertussis." Clinics in Laboratory Medicine 34, no. 2 (2014): 237–55. http://dx.doi.org/10.1016/j.cll.2014.02.003.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
34

Weisberg, Susan Shoshana. "Pertussis." Disease-a-Month 53, no. 10 (2007): 488–94. http://dx.doi.org/10.1016/j.disamonth.2007.09.012.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
35

Weinstein, Robert. "Pertussis." Infection Control & Hospital Epidemiology 11, no. 5 (1990): 268. http://dx.doi.org/10.1017/s0899823x00083148.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
36

Gabutti, Giovanni, Chiara Azzari, Paolo Bonanni, et al. "Pertussis." Human Vaccines & Immunotherapeutics 11, no. 1 (2014): 108–17. http://dx.doi.org/10.4161/hv.34364.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
37

Jakinovich, Andrea, and Sunil K. Sood. "Pertussis." Current Opinion in Pediatrics 26, no. 5 (2014): 597–604. http://dx.doi.org/10.1097/mop.0000000000000139.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
38

Kadin, M. "Pertussis." ASH Image Bank 2003, no. 0507 (2003): 100701. http://dx.doi.org/10.1182/ashimagebank-2003-100701.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
39

Lazarchick, J. "Pertussis." ASH Image Bank 2005, no. 0325 (2005): 101340. http://dx.doi.org/10.1182/ashimagebank-2005-101340.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
40

MATHIS, ROBERT D., BARBARA SHOAF, and TRACY I. WEINER. "Pertussis." Pediatric Emergency Care 9, no. 4 (1993): 218–20. http://dx.doi.org/10.1097/00006565-199308000-00010.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
41

Heininger, U. "Pertussis." Monatsschrift Kinderheilkunde 164, no. 11 (2016): 987–93. http://dx.doi.org/10.1007/s00112-016-0158-z.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
42

Plotkin, Stanley A. "Pertussis." Vaccine 7, no. 3 (1989): 195. http://dx.doi.org/10.1016/0264-410x(89)90227-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
43

Pluta, Ryszard M. "Pertussis." JAMA 304, no. 8 (2010): 922. http://dx.doi.org/10.1001/jama.304.8.922.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
44

Hildebrand, Erin. "Pertussis." Nursing 55, no. 5 (2025): 12–14. https://doi.org/10.1097/nsg.0000000000000190.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
45

Guiso, N., and D. Hozbor. "Bordetella pertussis Polymorphism and Pertussis Vaccines." Clinical and Vaccine Immunology 15, no. 2 (2008): 394–95. http://dx.doi.org/10.1128/cvi.00391-07.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
46

Hong, Jung Yun. "Update on pertussis and pertussis immunization." Korean Journal of Pediatrics 53, no. 5 (2010): 629. http://dx.doi.org/10.3345/kjp.2010.53.5.629.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
47

Herwaldt, Lorween A. "Pertussis and Pertussis Vaccines in Adults." JAMA: The Journal of the American Medical Association 269, no. 1 (1993): 93. http://dx.doi.org/10.1001/jama.1993.03500010103042.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
48

Herwaldt, L. A. "Pertussis and pertussis vaccines in adults." JAMA: The Journal of the American Medical Association 269, no. 1 (1993): 93–94. http://dx.doi.org/10.1001/jama.269.1.93.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
49

Hanawa, Tomoko, Kazunari Kamachi, Hideo Yonezawa, Toshiyuki Fukutomi, Hayato Kawakami, and Shigeru Kamiya. "Glutamate Limitation, BvgAS Activation, and (p)ppGpp Regulate the Expression of the Bordetella pertussis Type 3 Secretion System." Journal of Bacteriology 198, no. 2 (2015): 343–51. http://dx.doi.org/10.1128/jb.00596-15.

Pełny tekst źródła
Streszczenie:
ABSTRACTBordetella pertussisis a bacterium that is considered to be highly adapted to humans, and it has not been isolated from the environment. As this bacterium does not utilize sugars, the abundant supply of glutamate in Stainer Scholte (SS) medium enablesB. pertussisto grow efficiently in liquid culturein vitro, and as such, SS medium is a popular choice for laboratory experiments. However, the concentration of glutamate in thein vivoniche ofB. pertussisis quite low. We investigated the bacterial response to low concentrations of glutamate to elucidate bacterial physiology via the expressi
Style APA, Harvard, Vancouver, ISO itp.
50

Burgos-Rivera, Brunilís, Adria D. Lee, Katherine E. Bowden, et al. "Evaluation of Level of Agreement in Bordetella Species Identification in Three U.S. Laboratories during a Period of Increased Pertussis." Journal of Clinical Microbiology 53, no. 6 (2015): 1842–47. http://dx.doi.org/10.1128/jcm.03567-14.

Pełny tekst źródła
Streszczenie:
While PCR is the most common method used for detectingBordetella pertussisin the United States, most laboratories use insertion sequence481(IS481), which is not specific forB. pertussis; therefore, the relative contribution of otherBordetellaspecies is not understood. The objectives of this study were to evaluate the proportion of otherBordetellaspecies misidentified asB. pertussisduring a period of increased pertussis incidence, determine the level of agreement inBordetellaspecies detection between U.S. commercial laboratories and the CDC, and assess the relative diagnostic sensitivity of CDC
Style APA, Harvard, Vancouver, ISO itp.
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!